{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:26:59Z","timestamp":1791617219989,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100008644","name":"Faculty of Medicine, McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008644","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CIHR (CA)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12916-017-0865-x","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T11:22:48Z","timestamp":1495020168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis"],"prefix":"10.1186","volume":"15","author":[{"given":"Guillaume A.","family":"Mullie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Schwartzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Zwerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieynaba S.","family":"N\u2019Diaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,17]]},"reference":[{"issue":"6","key":"865_CR1","first-page":"593","volume":"11","author":"D Menzies","year":"2007","unstructured":"Menzies D, Joshi R, Pai M. Risk of tuberculosis infection and disease associated with work in health care settings. Int J Tuberc Lung Dis. 2007;11(6):593\u2013605.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"865_CR2","first-page":"226","volume":"16","author":"A Trajman","year":"2010","unstructured":"Trajman A, Menzies D. Occupational respiratory infections. Curr Opin Pulm Med. 2010;16(3):226\u201334.","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"865_CR3","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/arrd.1982.125.5.559","volume":"125","author":"A Catanzaro","year":"1982","unstructured":"Catanzaro A. Nosocomial tuberculosis. Am Rev Respir Dis. 1982;125(5):559\u201362.","journal-title":"Am Rev Respir Dis"},{"key":"865_CR4","volume-title":"Canadian Tuberculosis Standards","author":"Canadian Lung Association, Canadian Thoracic Society, Public Health Agency of Canada","year":"2014","unstructured":"Canadian Lung Association, Canadian Thoracic Society, Public Health Agency of Canada. Canadian Tuberculosis Standards. 7th ed. Ottawa: Public Health Agency of Canada; 2014.","edition":"7"},{"issue":"Rr-17","key":"865_CR5","first-page":"1","volume":"54","author":"PA Jensen","year":"2005","unstructured":"Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep. 2005;54(Rr-17):1\u2013141.","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"865_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.201302-0365OC","volume":"189","author":"SE Dorman","year":"2014","unstructured":"Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, Parker M, Garrett DO, Daley CL. Interferon-gamma release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States. Am J Respir Crit Care Med. 2014;189(1):77\u201387.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"865_CR7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.201501-0199OC","volume":"192","author":"TC King","year":"2015","unstructured":"King TC, Upfal M, Gottlieb A, Adamo P, Bernacki E, Kadlecek CP, Jones JG, Humphrey-Carothers F, Rielly AF, Drewry P, Murray K, DeWitt M, Matsubara J, O\u2019Dea L, Balser J, Wrighton-Smith P. T-SPOT. TB Interferon-g Release Assay performance in healthcare worker screening at nineteen US hospitals. Am J Respir Crit Care Med. 2015;192(3):367\u201373.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"865_CR8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043014","volume":"7","author":"A Zwerling","year":"2012","unstructured":"Zwerling A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Benedetti A, Dendukuri N, Menzies D, Pai M. TB screening in Canadian health care workers using interferon-gamma release assays. PLoS One. 2012;7(8), e43014.","journal-title":"PLoS One"},{"issue":"1","key":"865_CR9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054748","volume":"8","author":"A Zwerling","year":"2013","unstructured":"Zwerling A, Benedetti A, Cojocariu M, McIntosh F, Pietrangelo F, Behr MA, Schwartzman K, Menzies D, Pai M. Repeat IGRA testing in Canadian health workers: conversions or unexplained variability? PLoS One. 2013;8(1), e54748.","journal-title":"PLoS One"},{"issue":"5","key":"865_CR10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1513\/AnnalsATS.201508-532OC","volume":"13","author":"TE Gamsky","year":"2016","unstructured":"Gamsky TE, Lum T, Hung-Fan M, Green JA. Cumulative false positive QuantiFERON-TB Interferon-Gamma Release Assay results. Ann Am Thorac Soc. 2016;13(5):660\u20135.","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"865_CR11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1164\/rccm.201305-0831OC","volume":"188","author":"ML Slater","year":"2013","unstructured":"Slater ML, Welland G, Pai M, Parsonnet J, Banaei N. Challenges with QuantiFERON-TB Gold Assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med. 2013;188(8):1005\u201310.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"865_CR12","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1086\/668016","volume":"33","author":"LA Lambert","year":"2012","unstructured":"Lambert LA, Pratt RH, Armstrong LR, Haddad MB. Tuberculosis among healthcare workers, United States, 1995-2007. Infect Control Hospi Epidemiol. 2012;33(11):1126\u201332.","journal-title":"Infect Control Hospi Epidemiol"},{"issue":"10","key":"865_CR13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.7326\/0003-4819-133-10-200011210-00010","volume":"133","author":"D Menzies","year":"2000","unstructured":"Menzies D, Fanning A, Yuan L, FitzGerald JM. Hospital ventilation and risk for tuberculous infection in Canadian health care workers. Canadian Collaborative Group in Nosocomial Transmission of TB. Ann Intern Med. 2000;133(10):779\u201389.","journal-title":"Ann Intern Med"},{"issue":"4 Pt 1","key":"865_CR14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1164\/ajrccm.154.4.8887599","volume":"154","author":"K Schwartzman","year":"1996","unstructured":"Schwartzman K, Loo V, Pasztor J, Menzies D. Tuberculosis infection among health care workers in Montreal. Am J Respir Crit Care Med. 1996;154(4 Pt 1):1006\u201312.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9 Suppl 1","key":"865_CR15","first-page":"S98","volume":"2","author":"D Menzies","year":"1998","unstructured":"Menzies D, Fanning A, Yuan L, FitzGerald JM. Tuberculosis in health care workers: a multicentre Canadian prevalence survey: preliminary results. Canadian Collaborative Group in Nosocomial Transmission of Tuberculosis. Int J Tuberc Lung Dis. 1998;2(9 Suppl 1):S98\u2013102.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"865_CR16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.rmed.2012.12.008","volume":"107","author":"I Casas","year":"2013","unstructured":"Casas I, Esteve M, Guerola R, Garcia-Olive I, Roldan-Merino J, Martinez-Rivera C, Ruiz-Manzano J. Incidence of tuberculosis infection among healthcare workers: risk factors and 20-year evolution. Respir Med. 2013;107(4):601\u20137.","journal-title":"Respir Med"},{"issue":"12","key":"865_CR17","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1086\/502343","volume":"25","author":"SR Salpeter","year":"2004","unstructured":"Salpeter SR, Salpeter EE. Screening and treatment of latent tuberculosis among healthcare workers at low, moderate, and high risk for tuberculosis exposure: a cost-effectiveness analysis. Infect Control Hosp Epidemiol. 2004;25(12):1056\u201361.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"865_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/1471-2334-14-324","volume":"14","author":"A Muzzi","year":"2014","unstructured":"Muzzi A, Seminari E, Feletti T, Scudeller L, Marone P, Tinelli C, Minoli L, Marena C, Mangiarotti P, Strosselli M. Post-exposure rate of tuberculosis infection among health care workers measured with tuberculin skin test conversion after unprotected exposure to patients with pulmonary tuberculosis: 6-year experience in an Italian teaching hospital. BMC Infect Dis. 2014;14:324.","journal-title":"BMC Infect Dis."},{"issue":"5","key":"865_CR19","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1378\/chest.113.5.1184","volume":"113","author":"PA LoBue","year":"1998","unstructured":"LoBue PA, Catanzaro A. Effectiveness of a nosocomial tuberculosis control program at an urban teaching hospital. Chest. 1998;113(5):1184\u20139.","journal-title":"Chest"},{"issue":"7","key":"865_CR20","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/JOM.0b013e318254620f","volume":"54","author":"P Wrighton-Smith","year":"2012","unstructured":"Wrighton-Smith P, Sneed L, Humphrey F, Tao X, Bernacki E. Screening health care workers with interferon-gamma release assay versus tuberculin skin test: impact on costs and adherence to testing (the SWITCH study). J Occup Environ Med. 2012;54(7):806\u201315.","journal-title":"J Occup Environ Med"},{"key":"865_CR21","first-page":"28","volume":"26","author":"SH Ferebee","year":"1970","unstructured":"Ferebee SH. Controlled chemoprophylaxis trials in tuberculosis. A general review. Bibl Tuberc. 1970;26:28\u2013106.","journal-title":"Bibl Tuberc"},{"issue":"4","key":"865_CR22","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/ajrccm\/137.4.805","volume":"137","author":"CM Nolan","year":"1988","unstructured":"Nolan CM, Elarth AM. Tuberculosis in a cohort of Southeast Asian refugees. A five-year surveillance study. Am Rev Respir Dis. 1988;137(4):805\u20139.","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"865_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008;149(3):177\u201384.","journal-title":"Ann Intern Med"},{"key":"865_CR24","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11136-014-0858-6","volume":"24","author":"M Bauer","year":"2015","unstructured":"Bauer M, Ahmed S, Benedetti A, Greenaway C, Lalli M, Leavens A, Menzies D, Vadeboncoeur C, Vissandjee B, Wynne A, Schwartzman K. The impact of tuberculosis on health utility: a longitudinal cohort study. Qual Life Res. 2015;24:1227\u2013349.","journal-title":"Qual Life Res."},{"issue":"12","key":"865_CR25","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.5588\/ijtld.13.0423","volume":"17","author":"D Shepardson","year":"2013","unstructured":"Shepardson D, Marks SM, Chesson H, Kerrigan A, Holland DP, Scott N, Tian X, Borisov AS, Shang N, Heilig CM, Sterling TR, Villarino ME, Mac Kenzie WR. Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States. Int J Tuberc Lung Dis. 2013;17(12):1531\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"865_CR26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0196-6553(84)90001-4","volume":"12","author":"DE Snider Jr","year":"1984","unstructured":"Snider Jr DE, Cauthen GM. Tuberculin skin testing of hospital employees: infection, \"boosting,\" and two-step testing. Am J Infect Control. 1984;12(6):305\u201311.","journal-title":"Am J Infect Control"},{"issue":"14","key":"865_CR27","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1001\/jama.286.14.1740","volume":"286","author":"GH Mazurek","year":"2001","unstructured":"Mazurek GH, LoBue PA, Daley CL, Bernardo J, Lardizabal AA, Bishai WR, Iademarco MF, Rothel JS. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA. 2001;286(14):1740\u20137.","journal-title":"JAMA"},{"issue":"11","key":"865_CR28","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1086\/340397","volume":"34","author":"B Bellete","year":"2002","unstructured":"Bellete B, Coberly J, Barnes GL, Ko C, Chaisson RE, Comstock GW, Bishai WR. Evaluation of a whole-blood interferon-gamma release assay for the detection of Mycobacterium tuberculosis infection in 2 study populations. Clin Infect Dis. 2002;34(11):1449\u201356.","journal-title":"Clin Infect Dis"},{"key":"865_CR29","unstructured":"Further studies of geographic variation in naturally acquired tuberculin sensitivity. Bull World Health Organ. 1955;12(1-2):63\u201383."},{"issue":"10","key":"865_CR30","first-page":"847","volume":"3","author":"GW Comstock","year":"1999","unstructured":"Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis. 1999;3(10):847\u201350.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"865_CR31","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"GD Sanders","year":"2016","unstructured":"Sanders GD, Neumann PJ, Anirban B, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, Ganlats TG. Recommendations for conduct, methodological practices and reporting of cost-effectiveness analyses. Second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093\u20131103.32.","journal-title":"JAMA"},{"key":"865_CR32","volume-title":"Guidelines on the management of latent tuberculosis infection","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: WHO Press; 2015."},{"issue":"12","key":"865_CR33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030494","volume":"3","author":"R Joshi","year":"2006","unstructured":"Joshi R, Reingold AL, Menzies D, Pai M. Tuberculosis among health-care workers in low- and middle- income countries: a systematic review. PLoS Med. 2006;3(12), e494.","journal-title":"PLoS Med"},{"key":"865_CR34","doi-asserted-by":"crossref","first-page":"30781","DOI":"10.1038\/srep30781","volume":"6","author":"MW Moses","year":"2016","unstructured":"Moses MW, Zwerling A, Cattamanchi A, Denkinger CM, Banaei N, Kik SV, Metcalfe J, Pai M, Dowdy D. Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model. Nat Sci Rep. 2016;6:30781.","journal-title":"Nat Sci Rep."},{"issue":"1","key":"865_CR35","first-page":"16","volume":"11","author":"O Oxlade","year":"2007","unstructured":"Oxlade O, Schwartzman K, Menzies D. Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis. 2007;11(1):16\u201326.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"865_CR36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archinternmed.2008.524","volume":"169","author":"MA Perio de","year":"2009","unstructured":"de Perio MA, Tsevat J, Roselle GA, Kralovic SM, Eckman MH. Cost-effectiveness of interferon gamma release assays vs tuberculin skin tests in health care workers. Arch Intern Med. 2009;169(2):179\u201387.","journal-title":"Arch Intern Med"},{"key":"865_CR37","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1472-6963-11-247","volume":"11","author":"A Nienhaus","year":"2011","unstructured":"Nienhaus A, Schablon A, Costa JT, Diel R. Systematic review of cost and cost-effectiveness of different TB-screening strategies. BMC Health Serv Res. 2011;11:247.","journal-title":"BMC Health Serv Res."},{"issue":"12","key":"865_CR38","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1086\/668436","volume":"33","author":"MT Campo del","year":"2012","unstructured":"del Campo MT, Fouad H, Solis-Bravo MM, Sanchez-Uriz MA, Mahillo-Fernandez I, Esteban J. Cost-effectiveness of different screening strategies (single or dual) for the diagnosis of tuberculosis infection in healthcare workers. Infect Control Hosp Epidemiol. 2012;33(12):1226\u201334.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"865_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020770","volume":"6","author":"L Bradshaw","year":"2011","unstructured":"Bradshaw L, Davies E, Devine M, Flanagan P, Kelly P, O\u2019Connor K, Drobniewski F, Nikolayevskyy N, Abubakar I. The role of the interferon gamma release assay in assessing recent tuberculosis transmission in a hospital incident. PLoS One. 2011;6(6), e20770.","journal-title":"PLoS One"},{"issue":"23","key":"865_CR40","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1056\/NEJMoa1104875","volume":"365","author":"TR Sterling","year":"2011","unstructured":"Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh Jr CR, Chaisson RE, for the TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection. N Engl J Med. 2011;365(23):2156\u201366.","journal-title":"N Engl J Med"},{"key":"865_CR41","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-149-10-200811180-00003","volume":"149","author":"D Menzies","year":"2008","unstructured":"Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, Memish Z, Khan K, Gardam M, Hoeppner V, Benedetti A, Schwartzman K. Adverse events with 4\u00a0months of rifampin therapy or 9\u00a0months of isoniazid therapy for latent tuberculosis infection: a randomized trial. Ann Intern Med. 2008;149:689\u201397.","journal-title":"Ann Intern Med."},{"issue":"4","key":"865_CR42","first-page":"555","volume":"60","author":"International Union Against Tuberculosis Committee on Prophylaxis","year":"1982","unstructured":"International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull World Health Organ. 1982;60(4):555\u201364.","journal-title":"Bull World Health Organ."},{"issue":"2","key":"865_CR43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.09-0394","volume":"137","author":"CR Horsburgh Jr","year":"2010","unstructured":"Horsburgh Jr CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, Weinfurter P, and the Tuberculosis Epidemiologic Studies Consortium. Latent TB infection treatment, acceptance and completion in the United States and Canada. Chest. 2010;137(2):401\u20139.","journal-title":"Chest"},{"issue":"6","key":"865_CR44","first-page":"991","volume":"117","author":"DE Kopanoff","year":"1978","unstructured":"Kopanoff DE, Snider Jr DE, Caras GJ. Isoniazid-related hepatitis: a U.S. Public Health Service cooperative surveillance study. Am Rev Respir Dis. 1978;117(6):991\u20131001.","journal-title":"Am Rev Respir Dis"},{"issue":"11","key":"865_CR45","first-page":"181","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","unstructured":"Centers for Disease Control and Prevention. Trends in tuberculosis \u2013 United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(11):181\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"865_CR46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1164\/ajrccm\/142.4.848","volume":"142","author":"JM Fitzgerald","year":"1990","unstructured":"Fitzgerald JM, Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test. Am Rev Respir Dis. 1990;142(4):848\u201353.","journal-title":"Am Rev Respir Dis"},{"issue":"4 Pt 1","key":"865_CR47","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1164\/ajrccm.154.4.8887600","volume":"154","author":"RD Moore","year":"1996","unstructured":"Moore RD, Chaulk CP, Griffiths R, Cavalcante S, Chaisson RE. Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med. 1996;154(4 Pt 1):1013\u20139.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"865_CR48","first-page":"382","volume":"3","author":"R Wurtz","year":"1999","unstructured":"Wurtz R, White WD. The cost of tuberculosis: utilization and estimated charges for the diagnosis and treatment of tuberculosis in a public health system. Int J Tuberc Lung Dis. 1999;3(5):382\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10","key":"865_CR49","first-page":"931","volume":"4","author":"Z Taylor","year":"2000","unstructured":"Taylor Z, Marks SM, Rios Burrows NM, Weis SE, Stricof RL, Miller B. Causes and costs of hospitalization of tuberculosis patients in the United States. Int J Tuberc Lung Dis. 2000;4(10):931\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"15","key":"865_CR50","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1001\/archinte.1995.00430150057006","volume":"155","author":"RE Brown","year":"1995","unstructured":"Brown RE, Miller B, Taylor WR, Palmer C, Bosco L, Nicola RM, Zelinger J, Simpson K. Health-care expenditures for tuberculosis in the United States. Arch Intern Med. 1995;155(15):1595\u2013600.","journal-title":"Arch Intern Med"},{"key":"865_CR51","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2334-6-47","volume":"6","author":"PK Dewan","year":"2006","unstructured":"Dewan PK, Grinsdale J, Liska S, Wong E, Fallstad R, Kawamura LM. Feasibility, acceptability, and cost of tuberculosis testing by whole-blood interferon-gamma assay. BMC Infect Dis. 2006;6:47.","journal-title":"BMC Infect Dis."},{"issue":"23","key":"865_CR52","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1056\/NEJMsa021099","volume":"347","author":"K Khan","year":"2002","unstructured":"Khan K, Muennig P, Behta M, Zivin JG. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N Engl J Med. 2002;347(23):1850\u20139.","journal-title":"N Engl J Med"},{"issue":"12","key":"865_CR53","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.7326\/0003-4819-127-12-199712150-00001","volume":"127","author":"SR Salpeter","year":"1997","unstructured":"Salpeter SR, Sanders GD, Salpeter EE, Owens DK. Monitored isoniazid prophylaxis for low-risk tuberculin reactors older than 35\u00a0years of age: a risk-benefit and cost-effectiveness analysis. Ann Intern Med. 1997;127(12):1051\u201361.","journal-title":"Ann Intern Med"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-017-0865-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:19:12Z","timestamp":1692807552000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-017-0865-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,17]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1186\/s12916-017-0865-x","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,17]]},"article-number":"104"}}